Quantcast

Posts Tagged: biotech


Cystic fibrosis creates a thick sticky mucus that builds up in the airways causing infections and making it difficult to breathe Chronic pain is a common problem for patients which increases dramatically during the last months of life Those…

Continue Reading

What we saw when putting together our most recent Companies We Follow feature on AT T showed us a great collection of innovations regarding television services Interactive television services were discussed by a trio of patent applications published by…

Continue Reading

In a least one instance a major laboratory test provider has indicated in confidence that it would not be entering the Ebola testing market for three principle reasons the lack of availability of exclusivity for genetic testing the liability…

Continue Reading

A look into the recently published patent applications assigned to Dow from the U S Patent and Trademark Organization shows us that GMOs and herbicides have been a major area of focus for Dow and Dow AgroSciences its chief…

Continue Reading

It is tough to overstate the connection between the development of vaccines and public health however Since the use of vaccinations was first introduced by English physician Edward Jenner in many devastating diseases have either been eradicated or targeted…

Continue Reading

We saw in our coverage of Eli Lilly s patent applications a number of recently developed medications for the management of conditions like diabetes and inflammatory diseases but the company is also focused on developing solutions to medical problems…

Continue Reading

On the very same day that the U S jobs report shows unexpectedly weak growth the Federal Court of Australia issued a ruling directly opposite to the ruling rendered by the United States Supreme Court relative to gene patents…

Continue Reading

Capitol Hill is frequently the setting for both grandstanding and pandering and given the prevailing political and public sentiment it is also frequently a place where businesses find an inhospitable welcome A recent case in point Three senior members…

Continue Reading

The study looked at groups of patients receiving various levels of the PD A vaccine and evaluated them over a -month period Patients receiving the vaccine were given PD A subcutaneously in four vaccinations either in doses of micrograms…

Continue Reading

Although complementary patents and data exclusivity protection incentivize innovation in different ways and serve distinct purposes Patents provide protection for innovations that meet the standards of patentability and are novel nonobvious and useful In the context of biopharmaceuticals patents…

Continue Reading

Written by David J Kappos former Director of the USPTO The language of the Myriad decision did not on its face mandate drastic innovation-dampening action The Supreme Court chose to narrowly decide the Myriad case stating that a DNA…

Continue Reading

IDRI granted license rights to its world-class vaccine adjuvants to Immune Design Corporation IDC which was established in Seattle in with a focus on cancer allergies and certain infectious diseases The royalties and other funds received from IDC have…

Continue Reading